Radiological investigations in genitourinary cancer

Urological Oncology

Volumn , Issue , 2008, Pages 61-106

  Jacques, Audrey E T ^a   Reznek, Rodney H ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866993145     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-738-1_3     Document Type: Chapter

References (69)

1. Dalla PL. What is left of i.v. urography? Eur Radiol 2001;11(6):931-939.
2. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999;72(859):701-703.
3. Yousem DM, Gatewood OM, Goldman SM, Marshall FF. Synchronous and metachronous transitional cell carcinoma of the urinary tract: prevalence, incidence, and radiographic detection. Radiology 1988;167(3):613-618.
4. Kang CH, Yu TJ, Hsieh HH, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003;98(8):1620-1626.
5. Joffe SA, Servaes S, Okon S, Horowitz M. Multi-detector row CT urography in the evaluation of hematuria. Radiographics 2003;23(6):1441-1455.
6. McNicholas MM, Raptopoulos VD, Schwartz RK, et al. Excretory phase CT urography for opacifi cation of the urinary collecting system. AJR 1998;170:1261-1267.
7. Caoili EM, Cohan RH, Korobkin M, et al. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology 2002;222(2):353-360.
8. Kawashima A, Glockner JF, King BF Jr. CT urography and MR urography. Radiol Clin North Am 2003;41(5):945-961.
9. Roy C, Tuchmann C, Morel M, et al. Is there still a place for angiography in the management of renal mass lesions? Eur Radiol 1999;9(2):329-335.
10. Lin PH, Terramani TT, Bush RL, et al. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma. J Vasc Surg 2003;38:446-450.
11. Wunderlich H, Schumann S, Jantitzky V, et al. Increase of renal cell carcinoma incidence in central Europe. Eur Urol 1998;33(6):538-541.
12. Lui KW, Gervais DA, Arellano RA, Mueller PR. Radiofrequency ablation of renal cell carcinoma. Clin Radiol 2003;58(12):905-913.
13. Zagoria RJ. Imaging-guided radiofrequency ablation of renal masses. Radiographics 2004;24(suppl 1):S59-S71.
14. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unifi ed approach to underlying principles, techniques, and diagnostic imaging guidance. AJR 2000;174(2):323-331.
15. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000;217(3):633-646.
16. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002;167(1):10-15.
17. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR 2003;180(6):1509-1513.
18. Veltri A, De Fazio G, Malfi Tana V, et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur Radiol 2004; 14:2303-2310.
19. Wah TM, Arellano RS, Gervais DA, et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005;237:1097-1102.
20. Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma - the role of the serendipitously detected tumor. J Urol 1988;140(3):487-490.
21. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001;166(5):1611-1623.
22. Bosniak MA. The current radiological approach to renal cysts. Radiology 1986; 158:1-10.
23. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179(2):307-317.
24. Habboub HK, Abu-Yousef MM, Williams RD, et al. Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma. AJR 1997; 168(1):267-271.
25. Kallman DA, King BF, Hattery RR, et al. Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 1992;16(2):240-247.
26. Robbin ML. Ultrasound contrast agents: a promising future. Radiol Clin North Am 2001;39:399-414.
27. Jakobsen JA. Ultrasound contrast agents: clinical applications. Eur Radiol 2001; 11(8):1329-1337.
28. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51(2):203-205.
29. Israel GM, Bosniak MA. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR 2003;181(3):627-633.
30. Abecassis M, McLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, signifi cance, and management. Am J Surg 1985;149(6):783-788.
31. Glazer HS, Weyman PJ, Sagel SS, et al. Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR 1982;139(1):81-85.
32. Mitnick JS, Bosniak MA, Megibow AJ, Naidich DP. Non-functioning adrenal adenomas discovered incidentally on computed tomography. Radiology 1983;148: 495-499.
33. Francis IR, Smid A, Gross MD, et al. Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 1988;166(2):353-356.
34. Krestin GP, Freidmann G, Fishbach R, et al. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 1991; 15(1):104-110.
35. Frilling A, Tecklenborg K, Weber F, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004;136(6):1289-1296.
36. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR fi ndings. Radiology 1996;200(3):743-747.
37. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998;171:201-204.
38. Korobkin M, Brodeur FJ, Francis IR, et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR 1998;170(3):747-752.
39. Pena CS, Boland GW, Hahn PF, et al. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000;217(3):798-802.
40. Johnson CD, Dunnick NR, Cohan RH, Illescas FF. Renal adenocarcinoma: CT staging of 100 tumors. AJR 1987;148(1):59-63.
41. Fein AB, Lee JK, Balfe DM, et al. Diagnosis and staging of renal cell carcinoma: a comparison of MR imaging and CT. AJR 1987;148(4):749-753.
42. Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990;144(2 pt 1):243-245.
43. Clayman RV Jr, Gonzalez R, Fraley EE. Renal cancer invading the inferior vena cava: clinical review and anatomical approach. J Urol 1980;123(2):157-163.
44. Hatcher PA, Anderson EE, Paulson DF, et al. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 1991;145(1):20-23.
45. Catalano C, Fraioli F, Laghi A, et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR 2003;180(5):1271-1277.
46. MacVicar D. Staging of testicular germ cell tumours. Clin Radiol 1993;47:149-158.
47. Dixon AK, Ellis M, Sikora K. Computed tomography of testicular tumours: distribution of abdominal lymphadenopathy. Clin Radiol 1986;37(6):519-523.
48. Williams MP, Cook JV, Duchesne GM. Psoas nodes-an overlooked site of metastasis from testicular tumours. Clin Radiol 1989;40(6):607-609.
49. Coll DM, Uzzo RG, Herts BR, et al. 3-dimensional volume rendered computerized tomography for preoperative evaluation and intraoperative treatment of patients undergoing nephron sparing surgery. J Urol 1999;161(4):1097-1102.
50. Smith PA, Marshall FF, Corl FM, Fishman EK. Planning nephron-sparing renal surgery using 3D helical CT angiography. J Comput Assist Tomogr 1999;23(5): 649-654.
51. Coll DM, Herts BR, Davros WJ, Uzzo RG, Novick AC. Preoperative use of 3D volume rendering to demonstrate renal tumors and renal anatomy. Radiographics 2000; 20(2):431-438.
52. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001;21(spec. No.):S237-S254.
53. Mangar SA, Huddart RA, Parker CC, et al. Technological advances in radiotherapy for the treatment of localised prostate cancer. Eur J Cancer 2005;41(6):908-921.
54. Mallampati GK, Siegelman ES. MR imaging of the bladder. Magn Reson Imaging Clin North Am 2004;12:545-555.
55. Rominger MB, Kenney PJ, Morgan DE, et al. Gadolinium-enhanced MR imaging of renal masses. Radiographics 1992;12(6):1097-1116.
56. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995;197(2): 411-418.
57. Heiken JP, Forman HP, Brown JJ. Neoplasms of the bladder, prostate, and testis. Radiol Clin North Am 1994;32(1):81-98.
58. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 2004;24(suppl 1):S167-S180.
59. Rajesh A, Coakley FV. MR imaging and MR spectroscopic imaging of prostate cancer. Magn Reson Imaging Clin North Am 2004;12(3):557-579.
60. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195(2):385-390.
61. Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate-specifi c antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002;224(3):701-706.
62. Huch Boni RA, Boner JA, Debatin JF, et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 1995;50(9): 593-600.
63. Hull GW, Rabbani F, Abbas F, et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167(2 pt 1):528-534.
64. Yu KK, Hricak H, Alagappan R, et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997;202(3):697-702.
65. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with threedimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999;213(2):473-480.
66. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213(2):481-488.
67. Hricak H, Thoeni RF, Carroll PR, et al. Detection and staging of renal neoplasms: a reassessment of MR imaging. Radiology 1988;166(3):643-649.
68. Aslam Sohaib SA, Teh J, Nargund VH, et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol 2002;167(3):1271-1275.
69. Myneni L, Hricak H, Carroll PR. Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol 1991;68(6):571-578.